Comparison

Anti-Human EGFR (Clone 225) - Recombinant <i>in vivo</i> Functional Grade - 1.0 mg

Item no. LEIN-E360-1.0mg
Manufacturer Leinco Technologies
Amount 1 mg
Quantity options 1 mg 250 ug 5 mg 5 mg
Category
Type Antibody Monoclonal
Applications WB, FC, IF, IP, IHC, FA
Clone 225
Specific against other
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Shipping Condition Cool pack
Available
Manufacturer - Targets
EGFR
Shipping Temperature
2 - 8°C Wet Ice
Storage Conditions
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Product Description
Epidermal growth factor receptor (EGFR, also known as ErbB1 or HER 1) is a glycoprotein that belongs tothe receptor tyrosine kinase. It plays a role in activating signaling pathways essential, for cellularproliferation, differentiation, and survival1-3. During embryogenesis organogenesis and throughoutadulthood EGFR is involved in processes such as tissue growth, differentiation, maintenance, and repair2. Moreover, EGFR acts as a host factor for viral entry in diseases like hepatitis B4, hepatitis C5, andgastroenteritis6. It has also been found to play a role in SARS-CoV-2 infection7-9.Dysregulation of EGFR due to mutation or altered signaling is associated with diseases like Parkinson’s2, Alzheimer’s1, 2, and amyotrophic lateral sclerosis2. Additionally, it has been implicated in thedevelopment of cancers including lung, glioblastoma, brain, breast, colorectal, and ovarian3. The bindingof ligands to EGFR in cancer cells has been linked to abnormal cell proliferation, invasion, metastasis, angiogenesis, and reduced apoptosis10. Consequently, EGFR serves as a target for cancer treatmentsincluding monoclonal humanized antibodies such as panitumumab and cetuximab along with selectivesmall molecule inhibitors11-13.Human Anti-EGFR antibody, clone 225 is a research-grade biosimilar of the monoclonal antibody drugcetuximab. This chimeric antibody contains components from both humans and mice. 225 has beenextensively researched in forms of cancer such, as head and neck cell carcinoma, colorectal cancer, andnon-small cell lung cancer. Studies have shown that it can be effective when used alongsidechemotherapy or radiation therapy presenting an opportunity to enhance outcomes14-22.
Manufacturer - Research Area
Cancer, Immunology, Neuroscience
Concentration
≥ 5.0 mg/ml
Formulation
This recombinant monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Antigen Distribution
EGFR is overexpressed on the cell surfaces of various tumor cell types and is alsofound in the plasma membranes, cytoplasm, and cell junctions of many healthy tissues, including thoseassociated with the Skin – Epidermis development cluster of The Human Protein Atlas. EGFR is alsofound in the blood secretome.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close